|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 25, 2025
|
FY2024
12 months to Jan 27, 2024
|
FY2023
12 months to Jan 28, 2023
|
FY2022
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Deferred income tax provision (benefit) | |||||
| Stock-based compensation | |||||
| Provision for (recovery of) bad debt, net | |||||
| Gain on sale of fixed assets | |||||
| Loss on debt extinguishment | |||||
| Amortization of debt discount | |||||
| Amortization of debt issuance costs and other | |||||
| Change in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable, net | |||||
| Contract assets/liabilities, net | |||||
| Other current assets and inventories | |||||
| Other assets | |||||
| Income taxes receivable/payable | |||||
| Accounts payable | |||||
| Accrued liabilities, insurance claims, operating lease liabilities, and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of assets | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings on senior credit agreement, including term loans | |||||
| Principal payments on senior credit agreement, including term loans | |||||
| Debt issuance costs | |||||
| Repurchase of common stock | |||||
| Extinguishment of 2021 Convertible Notes | |||||
| Purchase of warrants | |||||
| Proceeds from borrowings on senior secured bridge loan | |||||
| Principal payments on senior secured bridge loan | |||||
| Exercise of stock options | |||||
| Restricted stock tax withholdings | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period (Note 8) | |||||
| Cash, cash equivalents and restricted cash at end of period (Note 8) | |||||
| Supplemental disclosure of other cash flow activities and non-cash investing and financing activities: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes, net | |||||
| Purchases of capital assets included in accounts payable or other accrued liabilities at period end | |||||
| Deferred financing costs included in accounts payable or other accrued liabilities at period end | |||||
| Supplemental disclosure of non-cash information: | |||||
| Common stock issued for acquisitions | |||||
Loading...